EBOS Group Limited has announced a special distribution totalling NZD $127.3 million (approximately AUD $104.6 million), with shareholders set to receive NZD $0.6150 per share in cash. The distribution, payable on 18 September 2026, will be sourced from retained earnings and represents a material capital return that offers investors insight into the company’s cash generation and capital allocation priorities. The ex-date of 27 August 2026 marks the key cutoff for determining eligibility.
The distribution carries partial imputation of 7.22 per cent, providing New Zealand resident taxpayers with imputation credits of NZD $0.04783333 per share. This partial imputation means that not all of the distribution has had corporate tax paid on it, which has implications for the tax efficiency of this payment depending on an investor’s personal tax position. The Resident Withholding Tax component of NZD $0.17090167 per share applies to non-residents and certain other taxpayers, with the combined imputation and RWT equalling 33 per cent of the gross taxable amount. For investors seeking clarity on their specific tax position, the partial imputation rate suggests EBOS has retained some earnings without pre-paying tax, which could reflect either the nature of recent earnings or a deliberate tax planning strategy.
EBOS has also implemented a Dividend Reinvestment Plan offering shareholders a 2.0 per cent discount to the Volume Weighted Average Sales Price. The discount applies to new shares issued under the DRP, with the VWAP calculated over the period from 31 August to 4 September 2026. The strike price will be announced on 9 September 2026, giving shareholders a clear reference point before the participation deadline of 31 August 2026. Shareholders wishing to participate in the DRP should note this deadline falls before the strike price is announced, requiring a decision based on the expected discount alone. This timing is worth monitoring, particularly for shareholders with a strategic view on the company’s valuation at that point.
Special distributions of this magnitude typically signal strong cash generation and often reflect a company’s confidence in future earnings capacity. The sourcing from retained earnings rather than operational cash flow suggests EBOS is returning accumulated profits to shareholders, a decision that may indicate management views the current capital position as adequate for growth plans. The 2.0 per cent DRP discount also suggests confidence, implying the company is comfortable issuing shares at a modest premium to the prevailing market price. For dividend-focused investors, the combination of yield and reinvestment flexibility offers meaningful optionality. The broader question is whether further special distributions can be expected, or if this represents a one-off capital return. Investors should monitor the company’s earnings guidance and capital expenditure plans in subsequent quarterly updates to assess the sustainability of distributions at this level. This announcement is price sensitive and has been flagged as material by the ASX.
View the full ASX announcement (PDF)
About EBOS Group Limited (ASX: EBO)
EBOS Group Limited is the largest pharmaceutical wholesaler and distributor across Australia, New Zealand, and Southeast Asia. The company provides pharmaceutical and wellness products to community pharmacies, hospitals, and healthcare facilities, and also operates an animal health product wholesale and retail business. The company is headquartered in Docklands, Australia and generates the majority of its revenue from pharmaceutical distribution services to community pharmacies and institutional healthcare providers.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
